Instituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (4)

2022

  1. New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming

    Journal of Experimental and Clinical Cancer Research, Vol. 41, Núm. 1

2021

  1. Armcx3 mediates susceptibility to hepatic tumorigenesis promoted by dietary lipotoxicity

    Cancers, Vol. 13, Núm. 5, pp. 1-22

2018

  1. Fibroblast growth factors 19 and 21 in acute liver damage

    Annals of Translational Medicine, Vol. 6, Núm. 12, pp. 257

2014

  1. Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis

    HEPATIC ONCOLOGY, Vol. 1, Núm. 2, pp. 241-252